Six months' chemotherapy for lymph node tuberculosis.
A retrospective report of the experience using the policy of six-month short-course chemotherapy as standard treatment for lymph node tuberculosis is presented. Forty-one patients completed 6 months' treatment as planned. All made a complete recovery, except one who had a 1 cm residual node at the completion of treatment, and one who relapsed four months after treatment, was re-treated and recovered. Nine other patients had changes in treatment because of side-effects (5), drug-resistant organisms (3) and pregnancy (1). Treatment was prolonged in another seven patients, four in error and three because of previous drug treatment. The results suggest that 6 months' treatment of lymph node tuberculosis may be as satisfactory as 9 months', and support the need for a control comparison of these regimens.
McCarthy
O R
OR
Newham Chest Clinic, London, U.K.
Rudd
R M
RM
D000293:Adolescent; D000328:Adult; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007194:India / Q000208:ethnology; D007538:Isoniazid / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011718:Pyrazinamide / Q000008:administration & dosage* / Q000627:therapeutic use; D012189:Retrospective Studies; D012293:Rifampin / Q000008:administration & dosage* / Q000627:therapeutic use; D014388:Tuberculosis, Lymph Node / Q000188:drug therapy*; D006113:United Kingdom
D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin